NewLink Genetics Corp (NASDAQ:NLNK)

5.10
Delayed Data
As of Jun 22
 -0.06 / -1.16%
Today’s Change
3.75
Today|||52-Week Range
19.30
-37.11%
Year-to-Date
No recent news for NewLink Genetics Corp.

Today’s Trading

Previous close5.16
Today’s open5.18
Day’s range4.88 - 5.24
Volume1,768,384
Average volume (3 months)984,427
Market cap$199.6M
Data as of 4:00pm ET, 06/22/2018

Growth & Valuation

Earnings growth (last year)+21.77%
Earnings growth (this year)+6.59%
Earnings growth (next 5 years)+19.24%
Revenue growth (last year)-19.73%
P/E ratioNM
Price/Sales8.84
Price/Book1.31

Competitors

 Today’s
change
Today’s
% change
OBSVObseva SA-0.22-1.47%
ATHXAthersys Inc+0.08+4.08%
NYMXNymox Pharmaceutical...+0.64+19.69%
KURAKura Oncology Inc-0.10-0.54%
Data as of 4:00pm ET, 06/22/2018

Financials

Next reporting dateJuly 27, 2018
EPS forecast (this quarter)-$0.58
Annual revenue (last year)$28.7M
Annual profit (last year)-$72.0M
Net profit margin-250.60%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, Chief Executive &
Scientific Officer
Charles J. Link
President &
Director
Nicholas N. Vahanian
Corporate headquarters
Ames, Iowa

Forecasts